Craig J. Thomas

Active 2004–2025

143
Papers
25,171
Citations
80
h-index
137
i10-index

Citations

Citations per year for Craig J. Thomas1994: 3 citations1998: 2 citations2004: 2 citations2005: 4 citations2006: 6 citations2007: 13 citations2008: 32 citations2009: 81 citations2010: 101 citations2011: 143 citations2012: 264 citations2013: 241 citations2014: 253 citations2015: 257 citations2016: 265 citations2017: 325 citations2018: 407 citations2019: 1,126 citations2020: 1,345 citations2021: 1,373 citations2022: 1,166 citations2023: 905 citations2024: 1,373 citations2025: 726 citations2026: 16 citations1995–1997: no citations, so these years are not shown1999–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,072 citing papers, 30.2% of this breakdownChina: 1,992 citing papers, 14.8% of this breakdownUnited Kingdom: 790 citing papers, 5.9% of this breakdownGermany: 735 citing papers, 5.4% of this breakdownItaly: 502 citing papers, 3.7% of this breakdownCanada: 484 citing papers, 3.6% of this breakdownJapan: 405 citing papers, 3% of this breakdownFrance: 398 citing papers, 3% of this breakdownSwitzerland: 293 citing papers, 2.2% of this breakdownSpain: 287 citing papers, 2.1% of this breakdownAustralia: 274 citing papers, 2% of this breakdownNetherlands: 269 citing papers, 2% of this breakdown
0%30.2%Other 22.1%

Fields

  • Medicine40.3%
  • Biochemistry, Genetics and Molecular Biology37.1%
  • Immunology and Microbiology8%
  • Neuroscience6.3%
  • Computer Science3.5%
  • Chemistry1%
  • Other3.8%

Topics

  • Cancer, Hypoxia, and Metabolism3.9%
  • Treatment of Major Depression3%
  • Tryptophan and brain disorders2.6%
  • Lymphoma Diagnosis and Treatment2.5%
  • Immune cells in cancer2%
  • Computational Drug Discovery Methods1.9%
  • Other84.1%

Coauthors

All papers

Open in search
  1. Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages

    Authors: , , , , , , , , , , , , , , , , , - Cell Metabolism 2015 cited by 1,375

  2. NMDAR inhibition-independent antidepressant actions of ketamine metabolites

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2016 cited by 1,619

  3. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

    Authors: , , , , , , , , , , - Pharmacological Reviews 2018 cited by 1,260

  4. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma

    Authors: , , , , , , , , , , , - Nature 2017 cited by 622

  5. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2017 cited by 664

  6. Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses

    Authors: , , , , , , , , , , , , - Science 2011 cited by 1,201

  7. Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

    Authors: , , , , , , , , , , , , , - Molecular Psychiatry 2021 cited by 263

  8. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher P. Austin, James Inglese, Marian H. Harris, John M. Asara, Gregory Stephanopoulos, Francesco G. Salituro, Shengfang Jin, Lenny Dang, Douglas S. Auld, Hee‐Won Park, Lewis C. Cantley, Craig J. Thomas, Matthew G. Vander Heiden - Nature Chemical Biology 2012 cited by 825

  9. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rita M. Braziel, Raymond R. Tubbs, James R. Cook, Dennis D. Weisenburger, Wing C. Chan, Susan K. Pierce, Louis M. Staudt - Nature 2010 cited by 1,663

  10. A multiprotein supercomplex controlling oncogenic signalling in lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa M. Rimsza, Fausto J. Rodríguez, Fayez Estephan, Matthias Holdhoff, Michael J. Kruhlak, Stephen M. Hewitt, Craig J. Thomas, Stefania Pittaluga, Thomas Oellerich, Louis M. Staudt - Nature 2018 cited by 403

  11. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jessica D. Kindrick, Cody J. Peer, Jun S. Wei, Mirit I. Aladjem, William D. Figg, Seth M. Steinberg, Jane B. Trepel, Frank T. Zenke, Yves Pommier, Javed Khan, Craig J. Thomas - Cancer Cell 2021 cited by 177

  12. PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Cancer 2024 cited by 98

  13. Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katherine E. Warren, Craig J. Thomas, Michelle Monje - Science Translational Medicine 2019 cited by 258

  14. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer

    Authors: , , , , , , , , , , , , , , , , , - eLife 2017 cited by 231

  15. Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Immunology 2011 cited by 644

  16. Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 cited by 499

  17. PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 cited by 327

  18. Pyruvate Kinase Controls Signal Strength in the Insulin Secretory Pathway

    Authors: , , , , , , , , , , , , , , , , , , - Cell Metabolism 2020 cited by 152

  19. Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas

    Authors: , , , , , , , , , , , , , , , , , , - Immunity 2020 cited by 139

  20. RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2016 cited by 311

  21. A Small Molecule That Inhibits OGT Activity in Cells

    Authors: , , , , , , , , , - ACS Chemical Biology 2015 cited by 290

  22. Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting

    Authors: , , , , , , , , , , , , , - Cell Metabolism 2018 cited by 231

  23. Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin

    Authors: , , , , , , , , , - Cell Metabolism 2016 cited by 338

  24. Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synuclein

    Authors: , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 266